載入...
Combined Diosmectite and Mesalazine Treatment for Mild-to-Moderate Ulcerative Colitis: A Randomized, Placebo-Controlled Study
BACKGROUND: The relapse rate of ulcerative colitis (UC) is high. The efficacy of combined diosmectite and mesalazine treatment for active mild-to-moderate UC was investigated. MATERIAL/METHODS: A total of 120 patients with UC were enrolled in this randomized, single-blind, placebo-controlled study....
Na minha lista:
| 發表在: | Med Sci Monit |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
International Scientific Literature, Inc.
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4301466/ https://ncbi.nlm.nih.gov/pubmed/25582578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.891400 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|